Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

Investing Articles

There’s A 14% Slump Ahead For AstraZenenca plc

| Alan Oscroft

Recovery might be coming for AstraZeneca plc (LON: AZN), but it'll take a few more years.

Read more »

Company Comment

AstraZeneca plc Rises On Cancer Treatment Prospects

| Mark Stones

No mention of a potential Pfizer bid in AstraZeneca plc's (LON: AZN) latest results.

Read more »

Investing Articles

Is There Still Time To Buy AstraZeneca plc?

| Rupert Hargreaves

Can AstraZeneca plc (LON: AZN) move higher, or are the company's shares overvalued?

Read more »

Investing Articles

Don’t Bank On An AstraZeneca plc Bid Windfall

| Tony Reading

AstraZeneca plc (LON:AZN) might be taken over but rival GlaxoSmithKline plc (LON:GSK) has just done a better deal.

Read more »

Investing Articles

AstraZeneca Plc’s 2 Greatest Weaknesses

| Kevin Godbold

Two standout factors undermining an investment in AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

AstraZeneca Plc’s Greatest Strengths

| Kevin Godbold

Two standout factors supporting an investment in AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

GlaxoSmithKline plc Tops The Pharmaceuticals sector

| Alan Oscroft

GlaxoSmithKline plc (LON: GSK) just edges out AstraZenenca plc (LON: AZN).

Read more »

Investing Articles

What AstraZeneca plc’s Investment Plans Mean For Earnings Growth

| Royston Wild

Royston Wild evaluates what AstraZeneca plc's (LON: AZN) capex drive is likely to mean for future earnings.

Read more »

Investing Articles

GlaxoSmithKline plc Stumbles But It’s Still A Buy

| Tony Reading

Drug setbacks highlight GlaxoSmithKline plc's (LON:GSK) robustness

Read more »

Investing Videos

GlaxoSmithKline plc vs AstraZeneca plc: Where Would You Put Your Money?

| Mark Stones

VIDEO: Two Fools put GlaxoSmithKline plc (LON:GSK) and AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

AstraZeneca plc: The ‘Sell’ That Has Been A Great ‘Buy’

| Harvey Jones

Analysts who damned AstraZeneca plc (LON: AZN) as a Sell missed a great Buy. So why are brokers still calling…

Read more »

Investing Articles

AstraZeneca Plc After The Patent Cliff

| Prabhat Sakya

AstraZeneca plc (LON:AZN) is set to recover strongly according to one Fool.

Read more »